Article thumbnail

Optimizing weight control in diabetes: antidiabetic drug selection

By S Kalra, B Kalra, AG Unnikrishnan, N Agrawal and S Kumar
Topics: Evidence 2 Practice
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in Type 2 diabetic patients.
  2. (2005). Alpha-glucosidase inhibitors for patients with Type 2 diabetes: Results from a Cochrane systematic review and meta-analysis. Diabetes Care.
  3. Diabesity: Therapeutic options.
  4. (2009). Diabetes medications and body weight. Expert Opin Drug Saf.
  5. Effects of lifestyle intervention on health care costs. Improving Control with Activity and Nutrition (ICAN).
  6. (2010). Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes. Diabetes Obes Metab.
  7. Efficacy and safety of incretin therapy in Type 2 diabetes. Systematic review and meta-analysis.
  8. (1996). Efficacy of insulin and sulfonylurea combination therapy in Type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Arch Intern Med.
  9. (1999). Efficacy of metformin in the treatment of NIDDM. Metaanalysis. Diabetes Care.
  10. Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: A meta-analysis. Diabetes Obes Metab.
  11. (2005). Long term non-pharmacologic weight loss interventions for adults with Type 2 diabetes. Cochrane Database Syst Rev.
  12. (2008). Long-acting insulin analogues versus NPH human insulin in Type 2 diabetes. A meta-analysis. Diabetes Res Clin Pract.
  13. Optimal insulin regimens in Type 2 diabetes mellitus: Systematic review and meta-analyses.
  14. Relative efficacy of randomly allocated diet, sulfonylurea, insulin or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
  15. (2008). Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: A meta-analysis of randomized controlled trials. Diabet Med.
  16. (2003). Six-month efficacy of benflurox vs. placebo or metformin in diet failed Type 2 diabetic patients. Acta Diabetol.